

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of respiratory burst (GO:0060267) | 8.65012637 |
| 2 | keratinization (GO:0031424) | 8.32435942 |
| 3 | complement activation (GO:0006956) | 8.03335055 |
| 4 | glomerular filtration (GO:0003094) | 7.11803112 |
| 5 | renal filtration (GO:0097205) | 6.37763839 |
| 6 | detection of bacterium (GO:0016045) | 5.98247268 |
| 7 | detection of other organism (GO:0098543) | 5.83476682 |
| 8 | protein activation cascade (GO:0072376) | 5.80863183 |
| 9 | establishment of skin barrier (GO:0061436) | 5.69655482 |
| 10 | regulation of respiratory burst (GO:0060263) | 5.61026250 |
| 11 | gonadal mesoderm development (GO:0007506) | 5.26589700 |
| 12 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 5.23050677 |
| 13 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 5.23050677 |
| 14 | Fc-gamma receptor signaling pathway (GO:0038094) | 5.23050677 |
| 15 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 5.20471357 |
| 16 | regulation of water loss via skin (GO:0033561) | 5.20289435 |
| 17 | antimicrobial humoral response (GO:0019730) | 5.07610238 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.02760180 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.95480349 |
| 20 | humoral immune response (GO:0006959) | 4.95228393 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.72720300 |
| 22 | antibacterial humoral response (GO:0019731) | 4.67651332 |
| 23 | detection of external biotic stimulus (GO:0098581) | 4.16581832 |
| 24 | retina homeostasis (GO:0001895) | 4.15508833 |
| 25 | germinal center formation (GO:0002467) | 3.90267892 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.87028946 |
| 27 | regulation of cellular extravasation (GO:0002691) | 3.86359468 |
| 28 | keratinocyte differentiation (GO:0030216) | 3.76153135 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.67950384 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.67203071 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.67203071 |
| 32 | multicellular organismal water homeostasis (GO:0050891) | 3.66948118 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.66870378 |
| 34 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64707746 |
| 35 | lipoxygenase pathway (GO:0019372) | 3.63738448 |
| 36 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.59650223 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.58338822 |
| 38 | chronic inflammatory response (GO:0002544) | 3.56005961 |
| 39 | surfactant homeostasis (GO:0043129) | 3.53963285 |
| 40 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.45740656 |
| 41 | skin morphogenesis (GO:0043589) | 3.43306867 |
| 42 | regulation of integrin activation (GO:0033623) | 3.35164681 |
| 43 | peptide cross-linking (GO:0018149) | 3.23173810 |
| 44 | regulation of antigen processing and presentation (GO:0002577) | 3.17843376 |
| 45 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.16597347 |
| 46 | cellular response to type I interferon (GO:0071357) | 3.15832177 |
| 47 | type I interferon signaling pathway (GO:0060337) | 3.15832177 |
| 48 | water homeostasis (GO:0030104) | 3.12690756 |
| 49 | response to type I interferon (GO:0034340) | 3.12241091 |
| 50 | eosinophil chemotaxis (GO:0048245) | 3.07159015 |
| 51 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00819507 |
| 52 | regulation of natural killer cell differentiation (GO:0032823) | 2.96266349 |
| 53 | regulation of monocyte chemotaxis (GO:0090025) | 2.94270112 |
| 54 | T-helper 1 type immune response (GO:0042088) | 2.93635950 |
| 55 | epidermal cell differentiation (GO:0009913) | 2.90932073 |
| 56 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87680778 |
| 57 | cellular response to interferon-gamma (GO:0071346) | 2.87553029 |
| 58 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.87460240 |
| 59 | B cell mediated immunity (GO:0019724) | 2.85514004 |
| 60 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.85154036 |
| 61 | positive regulation of T cell chemotaxis (GO:0010820) | 2.84784316 |
| 62 | regulation of T cell chemotaxis (GO:0010819) | 2.84784316 |
| 63 | myeloid dendritic cell differentiation (GO:0043011) | 2.80809094 |
| 64 | protein-chromophore linkage (GO:0018298) | 2.79049532 |
| 65 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.78599448 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 2.78027595 |
| 67 | eosinophil migration (GO:0072677) | 2.78009345 |
| 68 | immune response-activating signal transduction (GO:0002757) | 2.76650817 |
| 69 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.75084796 |
| 70 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.74067802 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.73987003 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.73987003 |
| 73 | positive regulation by symbiont of host defense response (GO:0052509) | 2.73987003 |
| 74 | modulation by symbiont of host defense response (GO:0052031) | 2.73987003 |
| 75 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.73987003 |
| 76 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.73987003 |
| 77 | defense response to protozoan (GO:0042832) | 2.69732784 |
| 78 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.68644950 |
| 79 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.68285782 |
| 80 | cellular extravasation (GO:0045123) | 2.67888702 |
| 81 | positive regulation of T cell migration (GO:2000406) | 2.67793290 |
| 82 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.67633787 |
| 83 | negative regulation of interferon-gamma production (GO:0032689) | 2.67594465 |
| 84 | response to interferon-gamma (GO:0034341) | 2.66567875 |
| 85 | regulation of T cell migration (GO:2000404) | 2.66330710 |
| 86 | defense response to Gram-negative bacterium (GO:0050829) | 2.63343324 |
| 87 | activation of immune response (GO:0002253) | 2.63236469 |
| 88 | positive regulation of pseudopodium assembly (GO:0031274) | 2.63011164 |
| 89 | dendritic cell chemotaxis (GO:0002407) | 2.62362378 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.59284464 |
| 91 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57469974 |
| 92 | NIK/NF-kappaB signaling (GO:0038061) | 2.56482335 |
| 93 | desmosome organization (GO:0002934) | 2.56062388 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.53528627 |
| 95 | production of molecular mediator of immune response (GO:0002440) | 2.52129233 |
| 96 | regulation of lymphocyte migration (GO:2000401) | 2.50840785 |
| 97 | response to interleukin-15 (GO:0070672) | 2.50048024 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.49710650 |
| 99 | positive regulation of lymphocyte migration (GO:2000403) | 2.48162419 |
| 100 | complement activation, classical pathway (GO:0006958) | 10.1011102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.72604015 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.15593705 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.84814414 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.31613193 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.14746487 |
| 6 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.43067944 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.97871845 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82940910 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54782848 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50617866 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.46120901 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45312939 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15464360 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.10816537 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.03408837 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87180625 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.85904961 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83435492 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.83080875 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82271111 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.81945349 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79548368 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78636731 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67365643 |
| 25 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.67241627 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65163919 |
| 27 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.63625137 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60902501 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.60279299 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58994667 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58415640 |
| 32 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.56953377 |
| 33 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54522208 |
| 34 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51529734 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47092137 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.46427966 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.45809697 |
| 38 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.43126180 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.41854435 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.37675203 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.35395209 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.35071600 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.34226129 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34046865 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.33848210 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31130139 |
| 47 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29371543 |
| 48 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29322285 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29215342 |
| 50 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27463032 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27301500 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24998966 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24906880 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24543341 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21317221 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21200840 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20367965 |
| 58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19669935 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19503183 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15693035 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.15043806 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14186346 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11629824 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10750365 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10278117 |
| 66 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09613352 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09337928 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07025381 |
| 69 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06965213 |
| 70 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05221119 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.01958213 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01344495 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01039777 |
| 74 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99462147 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98723099 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98502858 |
| 77 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97278045 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96783244 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96421652 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93925272 |
| 81 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92769270 |
| 82 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91506418 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91401310 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.91091435 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.91091435 |
| 86 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90687653 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 0.90569343 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.90106165 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90096480 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89712061 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89632200 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89372537 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89153752 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88341601 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88303806 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86260680 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85606940 |
| 98 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85198791 |
| 99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84672217 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84662218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.85327390 |
| 2 | MP0002796_impaired_skin_barrier | 4.29896016 |
| 3 | MP0003303_peritoneal_inflammation | 4.22730936 |
| 4 | MP0003436_decreased_susceptibility_to | 3.28049769 |
| 5 | MP0005275_abnormal_skin_tensile | 3.08511736 |
| 6 | MP0005387_immune_system_phenotype | 2.85878263 |
| 7 | MP0001790_abnormal_immune_system | 2.85878263 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.75122717 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.70717819 |
| 10 | MP0000685_abnormal_immune_system | 2.67055848 |
| 11 | MP0001800_abnormal_humoral_immune | 2.56284743 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.56037728 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.51272472 |
| 14 | MP0005671_abnormal_response_to | 2.43836927 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.37945436 |
| 16 | MP0005025_abnormal_response_to | 2.36928894 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.33877897 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.33523562 |
| 19 | MP0004947_skin_inflammation | 2.33057758 |
| 20 | MP0004782_abnormal_surfactant_physiolog | 2.27617129 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.19695923 |
| 22 | MP0009785_altered_susceptibility_to | 2.19347873 |
| 23 | MP0005501_abnormal_skin_physiology | 2.08990963 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.05212871 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 2.03278680 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.00022176 |
| 27 | MP0002452_abnormal_antigen_presenting | 1.98203689 |
| 28 | MP0002419_abnormal_innate_immunity | 1.90915171 |
| 29 | MP0002723_abnormal_immune_serum | 1.88579312 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.80850195 |
| 31 | MP0005166_decreased_susceptibility_to | 1.80731534 |
| 32 | MP0001819_abnormal_immune_cell | 1.80021977 |
| 33 | MP0000579_abnormal_nail_morphology | 1.75967665 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.74791494 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.64667434 |
| 36 | MP0003866_abnormal_defecation | 1.62748966 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.59434471 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.58920198 |
| 39 | MP0003763_abnormal_thymus_physiology | 1.55554175 |
| 40 | MP0008004_abnormal_stomach_pH | 1.50501543 |
| 41 | MP0001216_abnormal_epidermal_layer | 1.49843161 |
| 42 | MP0001873_stomach_inflammation | 1.48774551 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.43518390 |
| 44 | MP0006082_CNS_inflammation | 1.39077266 |
| 45 | MP0001663_abnormal_digestive_system | 1.31119712 |
| 46 | MP0002006_tumorigenesis | 1.27627437 |
| 47 | MP0000716_abnormal_immune_system | 1.27314206 |
| 48 | MP0003075_altered_response_to | 1.26270756 |
| 49 | MP0005310_abnormal_salivary_gland | 1.24513341 |
| 50 | MP0005023_abnormal_wound_healing | 1.21762527 |
| 51 | MP0009764_decreased_sensitivity_to | 1.20327852 |
| 52 | MP0005409_darkened_coat_color | 1.19449580 |
| 53 | MP0002405_respiratory_system_inflammati | 1.17908113 |
| 54 | MP0002398_abnormal_bone_marrow | 1.17791335 |
| 55 | MP0001851_eye_inflammation | 1.17656946 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.14030523 |
| 57 | MP0003448_altered_tumor_morphology | 1.11131312 |
| 58 | MP0000858_altered_metastatic_potential | 1.09881593 |
| 59 | MP0005464_abnormal_platelet_physiology | 1.09525916 |
| 60 | MP0002060_abnormal_skin_morphology | 1.07199350 |
| 61 | MP0009278_abnormal_bone_marrow | 1.06129129 |
| 62 | MP0004858_abnormal_nervous_system | 1.04860236 |
| 63 | MP0003941_abnormal_skin_development | 1.01475617 |
| 64 | MP0000343_altered_response_to | 1.00233406 |
| 65 | MP0002429_abnormal_blood_cell | 0.96719216 |
| 66 | MP0002933_joint_inflammation | 0.95949806 |
| 67 | MP0008469_abnormal_protein_level | 0.94884061 |
| 68 | MP0009931_abnormal_skin_appearance | 0.94444595 |
| 69 | MP0003045_fibrosis | 0.93605577 |
| 70 | MP0002998_abnormal_bone_remodeling | 0.92901713 |
| 71 | MP0005390_skeleton_phenotype | 0.92828234 |
| 72 | MP0010678_abnormal_skin_adnexa | 0.92680347 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.91464144 |
| 74 | MP0010771_integument_phenotype | 0.90730838 |
| 75 | MP0002722_abnormal_immune_system | 0.88217919 |
| 76 | MP0005164_abnormal_response_to | 0.87761297 |
| 77 | MP0000377_abnormal_hair_follicle | 0.86456188 |
| 78 | MP0004885_abnormal_endolymph | 0.86279007 |
| 79 | MP0009840_abnormal_foam_cell | 0.85842689 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.85022735 |
| 81 | MP0000249_abnormal_blood_vessel | 0.84467854 |
| 82 | MP0004510_myositis | 0.84082193 |
| 83 | MP0000477_abnormal_intestine_morphology | 0.81685467 |
| 84 | MP0000604_amyloidosis | 0.80761388 |
| 85 | MP0008260_abnormal_autophagy | 0.79948363 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.78764623 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.78371723 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.76690190 |
| 89 | MP0005388_respiratory_system_phenotype | 0.76239634 |
| 90 | MP0002133_abnormal_respiratory_system | 0.76239634 |
| 91 | MP0000490_abnormal_crypts_of | 0.74697743 |
| 92 | MP0003828_pulmonary_edema | 0.73428817 |
| 93 | MP0002098_abnormal_vibrissa_morphology | 0.73414220 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.73025965 |
| 95 | MP0001191_abnormal_skin_condition | 0.71880498 |
| 96 | MP0003279_aneurysm | 0.70952343 |
| 97 | MP0008438_abnormal_cutaneous_collagen | 0.70443669 |
| 98 | MP0005451_abnormal_body_composition | 0.69273028 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.68504351 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.68504351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 6.70087795 |
| 2 | Increased IgE level (HP:0003212) | 6.25698031 |
| 3 | Prostate neoplasm (HP:0100787) | 5.11176025 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.67640309 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.51359726 |
| 6 | Onycholysis (HP:0001806) | 4.49110610 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.46057863 |
| 8 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.40362281 |
| 9 | Alopecia of scalp (HP:0002293) | 4.30982910 |
| 10 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.25654855 |
| 11 | Gangrene (HP:0100758) | 3.80328015 |
| 12 | Vasculitis (HP:0002633) | 3.68134906 |
| 13 | Abnormality of the prostate (HP:0008775) | 3.67414221 |
| 14 | Corneal erosion (HP:0200020) | 3.56478475 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.50305214 |
| 16 | Palmoplantar hyperkeratosis (HP:0000972) | 3.48488348 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 3.43427127 |
| 18 | Urticaria (HP:0001025) | 3.39618159 |
| 19 | Malnutrition (HP:0004395) | 3.39107335 |
| 20 | Palmar hyperkeratosis (HP:0010765) | 3.25936983 |
| 21 | Hypotrichosis (HP:0001006) | 3.17033390 |
| 22 | Erythema (HP:0010783) | 3.11601979 |
| 23 | Recurrent bronchitis (HP:0002837) | 3.03253097 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.03156647 |
| 25 | Plantar hyperkeratosis (HP:0007556) | 3.00551903 |
| 26 | Orchitis (HP:0100796) | 2.98669215 |
| 27 | Leukocytosis (HP:0001974) | 2.97354045 |
| 28 | Abnormality of the axillary hair (HP:0100134) | 2.97090526 |
| 29 | Abnormality of secondary sexual hair (HP:0009888) | 2.97090526 |
| 30 | Hypergammaglobulinemia (HP:0010702) | 2.96216603 |
| 31 | Agammaglobulinemia (HP:0004432) | 2.94557441 |
| 32 | Pustule (HP:0200039) | 2.93029580 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 2.91138677 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.89115235 |
| 35 | Myositis (HP:0100614) | 2.87663863 |
| 36 | Spontaneous hematomas (HP:0007420) | 2.86968831 |
| 37 | Thick nail (HP:0001805) | 2.85630459 |
| 38 | Meningitis (HP:0001287) | 2.84729709 |
| 39 | Oral leukoplakia (HP:0002745) | 2.83593781 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.78766656 |
| 41 | Pruritus (HP:0000989) | 2.72876215 |
| 42 | Skin rash (HP:0000988) | 2.71499641 |
| 43 | Abnormality of complement system (HP:0005339) | 2.71371595 |
| 44 | Recurrent abscess formation (HP:0002722) | 2.66834380 |
| 45 | Keratoconjunctivitis (HP:0001096) | 2.66420397 |
| 46 | Recurrent skin infections (HP:0001581) | 2.66205153 |
| 47 | Sepsis (HP:0100806) | 2.65727832 |
| 48 | Ectropion (HP:0000656) | 2.64581212 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.63956640 |
| 50 | Glomerulonephritis (HP:0000099) | 2.63642982 |
| 51 | Cellulitis (HP:0100658) | 2.63473135 |
| 52 | Erythroderma (HP:0001019) | 2.59989707 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.56113413 |
| 54 | Optic neuritis (HP:0100653) | 2.53969892 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.53969892 |
| 56 | Parakeratosis (HP:0001036) | 2.53349566 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.52662579 |
| 58 | Hyperactive renin-angiotensin system (HP:0000841) | 2.51742712 |
| 59 | Hypohidrosis (HP:0000966) | 2.50690985 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47469636 |
| 61 | Hemoptysis (HP:0002105) | 2.45375067 |
| 62 | Osteomyelitis (HP:0002754) | 2.43336648 |
| 63 | Complement deficiency (HP:0004431) | 2.42151566 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.39696870 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.39431824 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.35508026 |
| 67 | Colitis (HP:0002583) | 2.34722907 |
| 68 | Mediastinal lymphadenopathy (HP:0100721) | 2.31928191 |
| 69 | Chronic diarrhea (HP:0002028) | 2.31833942 |
| 70 | Skin ulcer (HP:0200042) | 2.29038088 |
| 71 | Recurrent fungal infections (HP:0002841) | 2.28229050 |
| 72 | Emphysema (HP:0002097) | 2.27835514 |
| 73 | Inflammation of the large intestine (HP:0002037) | 2.26362801 |
| 74 | Xerostomia (HP:0000217) | 2.24830626 |
| 75 | Nephritis (HP:0000123) | 2.24412710 |
| 76 | Recurrent viral infections (HP:0004429) | 2.24050760 |
| 77 | Ridged nail (HP:0001807) | 2.23694327 |
| 78 | Neoplasm of the lung (HP:0100526) | 2.20755494 |
| 79 | Hypermelanotic macule (HP:0001034) | 2.18386751 |
| 80 | Gastrointestinal inflammation (HP:0004386) | 2.16431728 |
| 81 | Dehydration (HP:0001944) | 2.15392819 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.15009032 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.15009032 |
| 84 | Villous atrophy (HP:0011473) | 2.14733049 |
| 85 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.14733049 |
| 86 | Blepharitis (HP:0000498) | 2.14331460 |
| 87 | Autoimmune hemolytic anemia (HP:0001890) | 2.14308797 |
| 88 | Gingivitis (HP:0000230) | 2.13829746 |
| 89 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.13503427 |
| 90 | Palmoplantar keratoderma (HP:0000982) | 2.13104650 |
| 91 | Chronic otitis media (HP:0000389) | 2.12632039 |
| 92 | Abnormality of male internal genitalia (HP:0000022) | 2.10930304 |
| 93 | B lymphocytopenia (HP:0010976) | 2.08900385 |
| 94 | Recurrent sinusitis (HP:0011108) | 2.08831744 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08698130 |
| 96 | Obstructive lung disease (HP:0006536) | 2.08698130 |
| 97 | Abnormal blistering of the skin (HP:0008066) | 2.08531013 |
| 98 | Nail dystrophy (HP:0008404) | 2.07828332 |
| 99 | Autoimmune thrombocytopenia (HP:0001973) | 2.06153130 |
| 100 | Increased IgM level (HP:0003496) | 2.06074145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 6.19024854 |
| 2 | MAP4K1 | 4.33784911 |
| 3 | PRPF4B | 3.47545411 |
| 4 | RIPK4 | 3.31107674 |
| 5 | TYK2 | 2.84832053 |
| 6 | EPHA3 | 2.75138556 |
| 7 | TXK | 2.69924027 |
| 8 | BLK | 2.68766170 |
| 9 | FGFR4 | 2.30019892 |
| 10 | EPHB1 | 2.02749411 |
| 11 | JAK3 | 1.95475220 |
| 12 | KIT | 1.89405237 |
| 13 | ZAP70 | 1.88881048 |
| 14 | MST1R | 1.88681221 |
| 15 | JAK1 | 1.82962179 |
| 16 | RIPK1 | 1.82895880 |
| 17 | CDC42BPA | 1.80052868 |
| 18 | GRK6 | 1.74163214 |
| 19 | IKBKE | 1.72179178 |
| 20 | IRAK4 | 1.69020982 |
| 21 | MAP3K14 | 1.65663940 |
| 22 | CSK | 1.64085407 |
| 23 | FES | 1.61004161 |
| 24 | SYK | 1.51166662 |
| 25 | FGFR3 | 1.51066966 |
| 26 | JAK2 | 1.48334049 |
| 27 | TBK1 | 1.43901819 |
| 28 | IRAK1 | 1.41274320 |
| 29 | IRAK3 | 1.39915366 |
| 30 | MAP3K1 | 1.33646151 |
| 31 | PIK3CA | 1.31382340 |
| 32 | LYN | 1.31043033 |
| 33 | TGFBR1 | 1.29006053 |
| 34 | FER | 1.24109568 |
| 35 | MATK | 1.15648539 |
| 36 | HCK | 1.15362447 |
| 37 | STK24 | 1.14822734 |
| 38 | TGFBR2 | 1.10197389 |
| 39 | CSF1R | 1.05130270 |
| 40 | SIK3 | 1.00694842 |
| 41 | PDGFRA | 1.00500690 |
| 42 | MAP3K10 | 0.97833937 |
| 43 | BMPR2 | 0.97015233 |
| 44 | IKBKB | 0.95608038 |
| 45 | MAP3K3 | 0.94843563 |
| 46 | BTK | 0.93340991 |
| 47 | PRKG2 | 0.92232826 |
| 48 | TAOK2 | 0.88396027 |
| 49 | DDR2 | 0.87812952 |
| 50 | PKN2 | 0.85689056 |
| 51 | ACVR1B | 0.84493949 |
| 52 | TAOK1 | 0.83689096 |
| 53 | MAPK7 | 0.79694023 |
| 54 | LCK | 0.77736915 |
| 55 | NLK | 0.74824019 |
| 56 | ITK | 0.74545601 |
| 57 | MAP3K13 | 0.74382022 |
| 58 | MET | 0.74224620 |
| 59 | YES1 | 0.73108797 |
| 60 | MAP3K6 | 0.70312679 |
| 61 | TESK2 | 0.68077528 |
| 62 | FLT3 | 0.67593596 |
| 63 | GRK5 | 0.66845791 |
| 64 | MAP2K3 | 0.64993614 |
| 65 | FGR | 0.61507585 |
| 66 | RET | 0.61099741 |
| 67 | EIF2AK3 | 0.58986177 |
| 68 | EPHA2 | 0.56746964 |
| 69 | KSR2 | 0.56318777 |
| 70 | TAOK3 | 0.54638422 |
| 71 | MAP3K2 | 0.51739423 |
| 72 | PDK1 | 0.51688019 |
| 73 | FYN | 0.50953567 |
| 74 | MAPKAPK2 | 0.49383472 |
| 75 | PTK6 | 0.48857386 |
| 76 | PDPK1 | 0.48794433 |
| 77 | MAP3K11 | 0.47504657 |
| 78 | EPHB2 | 0.47502697 |
| 79 | LRRK2 | 0.42561033 |
| 80 | HIPK2 | 0.41173098 |
| 81 | TRIB3 | 0.40729995 |
| 82 | PDGFRB | 0.40511496 |
| 83 | MAPK4 | 0.40476280 |
| 84 | IGF1R | 0.39959398 |
| 85 | IRAK2 | 0.38940022 |
| 86 | MAP3K5 | 0.38412797 |
| 87 | PRKCQ | 0.36921483 |
| 88 | TEC | 0.35487170 |
| 89 | DMPK | 0.34810784 |
| 90 | PRKCD | 0.32464989 |
| 91 | ABL1 | 0.31089489 |
| 92 | MAPK11 | 0.30680843 |
| 93 | MAPK12 | 0.30669471 |
| 94 | SMG1 | 0.30080831 |
| 95 | CHUK | 0.26679579 |
| 96 | MAP2K6 | 0.25963108 |
| 97 | PIM1 | 0.25485765 |
| 98 | LMTK2 | 0.25077947 |
| 99 | SIK2 | 0.24794724 |
| 100 | INSR | 0.23740779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.87807628 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.87150130 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.39277390 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.26500774 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.22550504 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.21429321 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.67271443 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66703258 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37416536 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.10228042 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.06213091 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01289178 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87471916 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.78818038 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70083512 |
| 16 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63804238 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 1.62174232 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.60908369 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54939407 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.51925413 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.49066306 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47966578 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.47102013 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39443658 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.35203024 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30782341 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27073701 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.20086655 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19942598 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.19209305 |
| 31 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.18260186 |
| 32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16266232 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.15268892 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12809515 |
| 35 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06452662 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05015185 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04808653 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97474684 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97332854 |
| 40 | Measles_Homo sapiens_hsa05162 | 0.97151377 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92920698 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 0.92440578 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89896745 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.89141505 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87455884 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87059151 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85160869 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.83415049 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81666426 |
| 50 | Amoebiasis_Homo sapiens_hsa05146 | 0.80571784 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80368513 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79661859 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76718958 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76526146 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68184667 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62918593 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.62172587 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61472520 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61451575 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60754109 |
| 61 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60549116 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.60016457 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57234938 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56881912 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.56026392 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55210652 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55015591 |
| 68 | Mineral absorption_Homo sapiens_hsa04978 | 0.54578599 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.54370554 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.51868537 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51120140 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50888411 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49541790 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.43391095 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43259455 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.43112081 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41035337 |
| 78 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40553801 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40247348 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39184235 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38033924 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.37519915 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37214096 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35238670 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.33543962 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.33098794 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32117141 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32004162 |
| 89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.31295751 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31248597 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30527747 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30353898 |
| 93 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29558147 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28418612 |
| 95 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28294249 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28166130 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26117828 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25594686 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25542981 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25518655 |

